31 Jul Jacques LeLorier
Bio
Dr. Jacques Lelorier is a professor at the University of Montreal’s Departments of Medicine and Pharmacology as well as Chief of the Pharmacoepidemiology and Pharmacoeconomy research unit at the Hôtel-Dieu, Centre hospitalier de l’Université de Montréal. He is also an adjunct professor in the department of epidemiology biostatistics and public health at McGill University. He is a member of the Board’s Expert Human Drug Advisory Panel (HDAP), Review Board Patented Medicine Prices, Government of Canada as well as a member of the Ethics Committee of the Clinical Research Institute of Montreal (IRCM) and an AdHoc member of the Harvard Medical school promotions committee. To date, Dr. Lelorier has published more than 160 scientific articles, one book, 5 book chapters and directed 23 masters and PhDs students.
He got his medical degree at the University of Mexico, obtained a PhD in Pharmacology and Biostatistics and completed a residency in internal medicine in Minnesota. Upon moving to Montreal, he became assistant director of the clinical pharmacology department at Ayerst Laboratories and, later, a member of the pharmacology department of the faculty of medicine of the University of Montreal and of the department of medicine of the Hôtel-Dieu de Montréal hospital. He served as Physician in Chief at the Hotel-Dieu hospital and as Chairman of the Medicine Department at University of Montreal. He founded the medical obstetrics department at Sainte-Justine hospital and the service of Clinical Pharmacology at the Hôtel-Dieu de Montréal hospital.
Since establishing the organisational structure of CNODES, Dr. Lelorier has been the lead of the Quebec site, a member of the steering committee, and has played a significant role in the conception of many CNODES projects as an investigator and team member.
CNODES Projects
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Site Investigator, QuebecMajor bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies
Site Investigator, QuebecPerformance of the high-dimensional propensity score in adjusting for unmeasured confounders
Collaborator, QuebecHead to head comparison of the propensity score and the high-dimensional propensity score matching methods
Project Lead, QuebecPrescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis
Site Investigator, QuebecHydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study
Site Investigator, QuebecMethadone containing products used for opioid use disorder
Project LeadAtypical antipsychotics and cardiomyopathy: a population-based cohort study
Site Investigator, QuebecThe use of atypical antipsychotics and the risk of breast cancer
Co-Site Investigator, QuebecThe use of atypical antipsychotics and the risk of breast cancer
Co-Site Investigator, QuebecUse of proton pump inhibitors and development of acute myocardial infarction
Co-Site Investigator, QuebecProton pump inhibitors and the risk of Clostridium difficile infection
Co-Site Investigator, Quebec